“As reproductive endocrinologists, we see firsthand the challenges our patients face in accessing effective, affordable fertility treatments. We’re excited to participate in a study that has the potential to expand patient choice and increase access to care for those pursuing IVF.”
– Dr. John Park
Carolina Conceptions is proud to be a participating site in the GRACE Study, a nationwide Phase III clinical trial evaluating a new human menopausal gonadotropin (hMG).
Human menopausal gonadotropins help a patient’s ovaries produce more eggs during an assisted reproductive technology (ART) cycle.
The study, sponsored by GRANATA Bio, has recently reported strong enrollment momentum across the United States, highlighting a widespread interest in developing new, and potentially more accessible treatment options for patients undergoing IVF!
Carolina Conceptions is proud to be one of the leading fertility centers selected to contribute to this important research. Dr. John Park, one of our lead physicians, serves as a principal investigator in the trial. His experience in reproductive endocrinology and IVF protocols helps ensure that participants receive excellent care while also contributing valuable data to the scientific community.
The GRACE Study aims to evaluate the safety and efficacy of a new formulation that could offer patients an additional medication option during ovarian stimulation. Ongoing research like this plays a key role in improving fertility treatments, expanding patient access, and advancing reproductive medicine as a whole.
We are honored to support clinical research that moves our field forward, and we thank the patients who choose to participate – your involvement helps shape the future of fertility care!
For more details, you can read the full press release from GRANATA Bio here.
If you are a patient interested in participating in the GRACE study, please click here to learn more!